index	sentence	label
0	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1
1	The transcription factors @PROTEIN$ and retinoid X receptors participate in @COMPOUND$-induced locomotor activities.	1
2	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates @COMPOUND$-stimulated @PROTEIN$ release in female mice.	1
3	Human skin keratinocytes HaCat attacked by Staphylococcus aureus @PROTEIN$ showed a transient drop of cellular @COMPOUND$ levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.	1
4	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
5	In this study, we tested the hypothesis that the Angiopoietin 1 (Ang1)/@PROTEIN$ pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0
6	In this study, we tested the hypothesis that the Angiopoietin 1 (@PROTEIN$)/Tie2 pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0
7	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, @PROTEIN$ and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
8	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, Tie2 and @PROTEIN$ expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
9	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased @PROTEIN$, Tie2 and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
10	@COMPOUND$ also significantly increased doublecortin (@PROTEIN$, a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.	1
11	The data show that @COMPOUND$ treatment of RBMEC increased Ang1 and @PROTEIN$ gene and protein expression and promoted phosphorylated-Tie2 activity.	1
12	The data show that @COMPOUND$ treatment of RBMEC increased @PROTEIN$ and Tie2 gene and protein expression and promoted phosphorylated-Tie2 activity.	1
13	@COMPOUND$ treatment of stroke increases Ang1/@PROTEIN$ expression and thereby reduces BBB leakage and promotes vascular stabilization.	1
14	@COMPOUND$ treatment of stroke increases @PROTEIN$/Tie2 expression and thereby reduces BBB leakage and promotes vascular stabilization.	1
15	Ang1/@PROTEIN$ expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1
16	@PROTEIN$/Tie2 expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1
17	Based on the preclinical evidence of @PROTEIN$ I (Topo-1) upregulation by @COMPOUND$ (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	1
18	We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-@PROTEIN$-mediated @COMPOUND$ efflux.	1
19	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: @PROTEIN$, HAS2, and HAS3) during atresia in pig ovaries.	0
20	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of @PROTEIN$ (HAS: HAS1, HAS2, and HAS3) during atresia in pig ovaries.	0
21	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, HAS2, and @PROTEIN$) during atresia in pig ovaries.	0
22	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, @PROTEIN$, and HAS3) during atresia in pig ovaries.	0
23	Here, we have investigated how the post-synthetic acetylation of @PROTEIN$ affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from @COMPOUND$-treated cells.	0
24	Here we report a case of intragenic @PROTEIN$ microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by @COMPOUND$.	1
25	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
26	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
27	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
28	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
29	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
30	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
31	However, @COMPOUND$ treatment resulted in intracellular accumulation of @PROTEIN$ and prevented its translocation to the cell surface.	1
32	@PROTEIN$ digestion, fluorescence anisotropy, and NMR experiments presented here were designed to resolve the issue and show that in arm-dimerization domain, the arms are structured, although differently, in the presence and absence of @COMPOUND$.	0
33	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	0
34	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	1
35	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	0
36	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	1
37	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (@PROTEIN$)1/2, one of the critical regulators of Cx43.	1
38	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (ERK)1/2, one of the critical regulators of @PROTEIN$.	1
39	The relative gene expression of @PROTEIN$ 0.05) in-@COMPOUND$ calves compared with+ Cu or-Cu+Mn calves.	1
40	Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1
41	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1
42	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1
43	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
44	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
45	Hepatic antioxidant status viz, @COMPOUND$ (GSH), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
46	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
47	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
48	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
49	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
50	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
51	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
52	They potentiate @COMPOUND$-induced @PROTEIN$ secretion and may be responsible for up to 70% of postprandial insulin secretion.	1
53	However, in supraphysiological doses, @PROTEIN$ administration may completely normalize beta as well as alpha cell sensitivity to @COMPOUND$.	1
54	@COMPOUND$ (CPF), a commonly used organophosphorus insecticide, induces @PROTEIN$ inhibition and cholinergic toxicity.	1
55	The esterase and @PROTEIN$ activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
56	The @PROTEIN$ and lipase activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
57	Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0
58	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
59	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
60	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
61	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
62	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
63	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
64	The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1
65	The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1
66	The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1
67	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
68	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
69	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
70	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
71	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
72	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
73	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
74	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
75	Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G&gt;C with circulating @COMPOUND$ levels, @PROTEIN$ levels, and body mass index.	0
76	Joint analysis of individual participants' data from 17 studies on the association of the @PROTEIN$ variant-174G&gt;C with circulating @COMPOUND$ levels, interleukin-6 levels, and body mass index.	0
77	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with mPEG-@COMPOUND$ (mPEG-Suc, 5 kDa).	1
78	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble @COMPOUND$ derivative at Cys 1 and Cys 7, was reacted with mPEG-succinimide (mPEG-Suc, 5 kDa).	1
79	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with @COMPOUND$-succinimide (mPEG-Suc, 5 kDa).	1
80	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
81	Liver @COMPOUND$ DNA adducts and acrylamide and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
82	Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal @COMPOUND$ @PROTEIN$ adducts were also determined.	1
83	Liver glycidamide DNA adducts and @COMPOUND$ and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
84	Molecular and biochemical characterization of a distinct @PROTEIN$ involved in @COMPOUND$ production from Aeromonas media.	1
85	TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0
86	TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0
87	@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0
88	TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0
89	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1
90	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1
91	EDTA or glutathione notably inhibited the enzymatic activities of @PROTEIN$, whereas @COMPOUND$ and SDS activated them.	1
92	These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1
93	These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1
94	Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1
95	They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1
96	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse @PROTEIN$ catalytic activity with cytotoxicity lower than @COMPOUND$ and SI higher than DDC and DDI.	1
97	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, @COMPOUND$ clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and folate deficiencies as the dominant variables.	1
98	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, urea clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and @COMPOUND$ deficiencies as the dominant variables.	1
99	In summary @PROTEIN$ resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and @COMPOUND$ deficits were the major determinants in adults.	1
100	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (@PROTEIN$).	1
101	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of @PROTEIN$ (GDH).	1
102	The effect of this diet alone or after 2 weeks of treatment with @COMPOUND$ or glimepiride on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
103	The effect of this diet alone or after 2 weeks of treatment with rosiglitazone or @COMPOUND$ on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
104	Rosiglitazone corrected the altered parameters measured, except for liver TGs ; similarly, @COMPOUND$ reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	1
105	@COMPOUND$ corrected the altered parameters measured, except for liver TGs ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
106	Rosiglitazone corrected the altered parameters measured, except for liver @COMPOUND$ ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
107	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
108	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
109	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
110	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
111	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
112	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0
113	While studies have shown that @COMPOUND$ does not exhibit nonspecific actions on @PROTEIN$, its effects on steroid hormone production have not been reported.	0
114	Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring alkaline phosphatase (@PROTEIN$) and tartrate-resistant acid phosphatase, respectively.	0
115	Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring @PROTEIN$ (ALP) and tartrate-resistant acid phosphatase, respectively.	0
116	MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or @COMPOUND$ at 37 degrees C for 6 and 18 h. @PROTEIN$ activity in cell lysate was measured.	0
117	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-@COMPOUND$, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.	0
118	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-@COMPOUND$, and (3)H-methylaminoisobutyric acid, respectively.	0
119	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, @COMPOUND$ for fever, C-reactive protein (@PROTEIN$), and total and percent gammadeltaT-cells.	0
120	@PROTEIN$ single nucleotide polymorphism G2677T/A and haplotype are correlated with response to @COMPOUND$-cisplatin chemotherapy in patients with non-small-cell lung cancer.	1
121	To elucidate the mechanism by which @COMPOUND$ regulates adipose triglyceride @PROTEIN$ (ATGL).	1
122	This finding led the authors to propose that @PROTEIN$ may be involved in the pathogenesis of psoriasis through its potential role in @COMPOUND$ biosynthesis and stimulation of keratinocyte proliferation.	1
123	In this study, we began the characterization of @PROTEIN$ protein in order to determine whether it might play a role in @COMPOUND$ biosynthesis.	0
124	The preference for NAD(+) suggests that @PROTEIN$ is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for @COMPOUND$ biosynthesis in human keratinocytes.	1
125	@COMPOUND$ alone evoked effects similar to low N/@PROTEIN$ doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/OFQ.	0
126	@COMPOUND$ modulation of alpha-, @PROTEIN$, and the norepinephrine transporter in an animal model of depression.	1
127	@COMPOUND$ modulation of alpha-, gamma-synuclein, and the @PROTEIN$ in an animal model of depression.	1
128	The @PROTEIN$-selective antidepressant @COMPOUND$ (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	1
129	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1
130	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1
131	Molecular dynamics simulation techniques have been used to study the unbinding pathways of @COMPOUND$) from the ligand-binding pocket of the vitamin D receptor (@PROTEIN$).	1
132	Toll-like receptor 4 (@PROTEIN$-4)/myeloid differentiation protein-2 complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
133	Toll-like receptor 4 (TLR-4)/myeloid differentiation @PROTEIN$ complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
134	Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by @PROTEIN$, which involves limited conformational changes including @COMPOUND$ trans to cis isomerization.	1
135	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in @PROTEIN$ secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.	1
136	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of @PROTEIN$ prenylation via suppression of the mevalonate pathway.	1
137	The influence of the prenylation status of @PROTEIN$ on the observed changes in endothelial cell growth under high @COMPOUND$ conditions has not previously been examined.	0
138	Association of the @PROTEIN$ gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of @COMPOUND$ monotherapy in metastatic breast cancer patients.	1
139	We evaluated the association between clinical outcome (safety and efficacy) of @COMPOUND$ monotherapy in metastatic breast cancer patients with @PROTEIN$ gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	1
140	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
141	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
142	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
143	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
144	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
145	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
146	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
147	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
148	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
149	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
150	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
151	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated @PROTEIN$ and Tie2 in the SVZ compared with MCAo control.	1
152	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and @PROTEIN$ in the SVZ compared with MCAo control.	1
153	@COMPOUND$ significantly increased the expression of @PROTEIN$ and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
154	@COMPOUND$ significantly increased the expression of SDF1 and @PROTEIN$ in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
155	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1
156	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
157	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
158	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
159	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
160	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
161	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
162	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
163	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
164	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
165	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
166	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
167	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
168	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
169	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
170	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
171	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
172	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
173	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
174	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
175	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
176	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
177	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
178	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
179	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and SOD, @PROTEIN$ and GPx activities, were determined.	1
180	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and @PROTEIN$, CAT and GPx activities, were determined.	0
181	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1
182	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1
183	@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
184	Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
185	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
186	To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
187	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
188	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
189	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. @COMPOUND$ plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
190	Furthermore, lysosomal integrity was disrupted after addition of @COMPOUND$ and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
191	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both @COMPOUND$ and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	0
192	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
193	Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1
194	An enzymatic reaction between @COMPOUND$ and @PROTEIN$ produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	1
195	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and @COMPOUND$ are the primary sources of carbon and nitrogen.	0
196	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and @COMPOUND$.	0
197	Lung injury was assessed by measuring vascular permeability (via @COMPOUND$), edema, neutrophil infiltration (via myeloperoxidase (@PROTEIN$), and expression of proinflammatory cytokines.	0
198	The inducible form of @PROTEIN$ (NOS2) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
199	The inducible form of nitric oxide synthase (@PROTEIN$) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
200	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
201	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
202	Here, PCA is applied to three problems in @PROTEIN$ research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of @COMPOUND$ (CS).	1
203	Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
204	Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
205	It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
206	It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
207	It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
208	It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
209	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0
210	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0
211	We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1
212	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0
213	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0
214	Our results showed that @PROTEIN$ abolished the effect of the oxidant, protecting spermatozoa against reactive @COMPOUND$ species, and improving both sperm motility and chromatin status during incubation.	1
215	Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1
216	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
217	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
218	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
219	The affinity characteristics of developed immunosensors were investigated in reaction with @COMPOUND$, and @PROTEIN$.	1
220	The detection limit for @COMPOUND$ was 10 ngmL(-1) and for @PROTEIN$ 0.01 ngmL(-1).	0
221	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
222	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
223	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
224	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
225	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
226	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
227	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
228	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
229	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
230	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
231	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
232	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
233	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
234	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
235	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
236	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
237	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
238	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
239	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
240	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
241	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
242	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
243	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
244	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
245	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and @PROTEIN$ A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
246	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (@PROTEIN$) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
247	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (@PROTEIN$, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
248	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, @PROTEIN$) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
249	@PROTEIN$ is expressed in the rat DVC, where mRNA is localized to neurons that exhibit electrophysiological sensitivity to @COMPOUND$ imbalance.	0
250	@PROTEIN$-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with @COMPOUND$ in hippocampal slices.	1
251	Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-@PROTEIN$ polymerization with @COMPOUND$ in hippocampal slices.	1
252	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
253	Immunolocalization of @PROTEIN$ in the boar epididymis: the effect of GnRH agonist @COMPOUND$.	0
254	TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to @PROTEIN$ expression or to the response to @COMPOUND$.	0
255	ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate @PROTEIN$)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
256	@PROTEIN$ (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
257	ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/@PROTEIN$ (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
258	ANP (atrial @PROTEIN$) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
259	ANP (@PROTEIN$) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
260	Overexpression of Ets-1 enhanced significantly @PROTEIN$ mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	0
261	Overexpression of Ets-1 enhanced significantly Npr1 mRNA levels, protein expression, GC activity and @PROTEIN$-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
262	Overexpression of @PROTEIN$ enhanced significantly Npr1 mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
263	Decreased oral absorption of @COMPOUND$ after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-@PROTEIN$ to the first-pass metabolism in intestinal epithelial cells.	0
264	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
265	Inhibition of @PROTEIN$ kinase by @COMPOUND$ : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	1
266	The investigation included simulated docking experiments to fit @COMPOUND$ within the binding pocket of @PROTEIN$ followed by experimental in vitro and in vivo validations.	1
267	@COMPOUND$ was found to optimally fit within the binding pocket of @PROTEIN$ via several attractive interactions with key amino acids.	1
268	Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1
269	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, @PROTEIN$-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
270	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of @PROTEIN$-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
271	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, TNF-alpha-, and @PROTEIN$-mRNA in the THP-1 human monocytic cell line.	0
272	Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the @COMPOUND$ could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
273	Altogether these changes offer a straightforward explanation for how following the addition of @COMPOUND$+), the coelenterazine could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
274	Effects of gram-negative bacterial @COMPOUND$ (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma urea-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0
275	Effects of gram-negative bacterial lipopolysaccharide (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma @COMPOUND$-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0
276	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, tumor necrosis factor-alpha, and @PROTEIN$ 0.01).	0
277	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, @PROTEIN$-alpha, and haptoglobin 0.01).	0
278	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, @PROTEIN$, tumor necrosis factor-alpha, and haptoglobin 0.01).	0
279	Plasma @COMPOUND$-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum @PROTEIN$ was not affected (P &gt; or = 0.26) by LPS or Met.	0
280	We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked @COMPOUND$, which was useful for the purification of @PROTEIN$.	1
281	Immobilization of @PROTEIN$ on the @COMPOUND$ modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	1
282	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing @PROTEIN$ on the @COMPOUND$ modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	1
283	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as @PROTEIN$, nitrite/nitrate, glutathione peroxidase and @COMPOUND$ were performed.	0
284	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as superoxide dismutase, nitrite/nitrate, @PROTEIN$ and @COMPOUND$ were performed.	0
285	The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0
286	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for @COMPOUND$ instead of glycine (p.Gly849Arg).	1
287	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for arginine instead of @COMPOUND$ (p.Gly849Arg).	1
288	@COMPOUND$-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by resveratrol.	0
289	Conjugated linoleic acid-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by @COMPOUND$.	1
290	Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0
291	Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1
292	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
293	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
294	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
295	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
296	@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1
297	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
298	It has been shown that the removal efficiency of @PROTEIN$ increased with the increasing applied current density and increasing PAC and @COMPOUND$ (2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.	1
299	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
300	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
301	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
302	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
303	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
304	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
305	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
306	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
307	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
308	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
309	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
310	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1
311	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1
312	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
313	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
314	Importantly, @PROTEIN$ and PAI-1 proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor @COMPOUND$.	1
315	Importantly, tPA and @PROTEIN$ proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor @COMPOUND$.	1
316	To determine whether hCG stimulation of tPA and @PROTEIN$ requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0
317	To determine whether hCG stimulation of @PROTEIN$ and PAI-1 requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0
318	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
319	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
320	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
321	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
322	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
323	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
324	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
325	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
326	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0
327	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
328	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0
329	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
330	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
331	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
332	@COMPOUND$ was able to reduce @PROTEIN$-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
333	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, @PROTEIN$ and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
334	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and @PROTEIN$ at both the protein and transcript (mRNA) level in HUASMC.	1
335	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of @PROTEIN$, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
336	However the quercetin metabolites, @COMPOUND$, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on @PROTEIN$-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	0
337	@COMPOUND$, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases @PROTEIN$ expression.	1
338	Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0
339	Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1
340	Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0
341	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
342	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
343	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
344	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
345	The angiogenic potential of vascular endothelial growth factor (@PROTEIN$) and its @COMPOUND$ pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	1
346	@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1
347	@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1
348	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	1
349	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	0
350	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	0
351	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	1
352	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	0
353	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	1
354	The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0
355	Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0
356	Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0
357	@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
358	Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
359	Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1
360	Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
361	Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
362	Light stimulates @COMPOUND$ hydrolysis via the G-protein @PROTEIN$, which directly binds to and activates phosphodiesterase.	1
363	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of @PROTEIN$ (monocyte chemoattractant protein-1) and kidney cortex MCP-1 gene expression.	1
364	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of MCP-1 (@PROTEIN$) and kidney cortex MCP-1 gene expression.	1
365	@COMPOUND$ oligonucleotide-induced expression of truncated @PROTEIN$ in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.	1
366	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1
367	In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of @COMPOUND$ and the @PROTEIN$ activity in cultured rat islet.	0
368	Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0
369	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, @PROTEIN$ (CBG), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
370	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, corticosteroid binding globulin (@PROTEIN$), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
371	Total serum @COMPOUND$ and @PROTEIN$ were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	0
372	However, we also observed that @COMPOUND$ (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced @PROTEIN$ expression in breast cancer cells.	1
373	Effects of dissolved @COMPOUND$ tension and agitation rate on the production of heat-shock protein @PROTEIN$ 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	0
374	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1
375	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1
376	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
377	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
378	The addition of a bisecting @COMPOUND$ residue by beta(1,4)-@PROTEIN$ (GnTIII) is known to control the processing of N-linked glycans in mammals, for example by preventing alpha(1,6)-fucosylation of the core glycan.	1
379	Both CTSs targeted enhanced @PROTEIN$ (eYFP) to a @COMPOUND$-sensitive compartment, indicative of Golgi localization.	0
380	Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1
381	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
382	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
383	@COMPOUND$, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
384	Curcumin, demethoxycurcumin and @COMPOUND$ differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
385	Curcumin, @COMPOUND$ and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
386	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
387	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
388	Intracellular production of @PROTEIN$ and IL-2 after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
389	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
390	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
391	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
392	The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by ethylene and @COMPOUND$ treatments, respectively.	1
393	The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by @COMPOUND$ and methyl jasmonate treatments, respectively.	1
394	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
395	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
396	@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1
397	@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0
398	Although the levels of IL-4, IL-13, IL-10, and @PROTEIN$/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
399	Although the levels of @PROTEIN$, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
400	Although the levels of IL-4, @PROTEIN$, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
401	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and @PROTEIN$ were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
402	Although the levels of IL-4, IL-13, @PROTEIN$, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
403	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, @PROTEIN$ and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	1
404	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
405	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
406	Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1
407	For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
408	For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
409	Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
410	Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
411	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0
412	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0
413	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
414	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
415	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
416	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
417	Inhibition of LTP by beta-amyloid is prevented by activation of @PROTEIN$ and stimulation of the @COMPOUND$/PKA signalling pathway.	0
418	The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0
419	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
420	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
421	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
422	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0
423	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0
424	Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0
425	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0
426	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
427	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
428	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
429	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
430	These @PROTEIN$ are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous @COMPOUND$ and aldehydes.	1
431	We measured the ability to increase GABA in eight healthy subjects by comparing the binding of ((11)C) @COMPOUND$, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (@PROTEIN$).	0
432	@PROTEIN$ blockade resulted in significant increases in mean (+/-SD) ((11)C) @COMPOUND$-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	1
433	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
434	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
435	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
436	Radioisotopic localization of (90) @COMPOUND$-ibritumomab tiuxetan in patients with @PROTEIN$+ non-Hodgkin's lymphoma.	1
437	In sum, @COMPOUND$ exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like @PROTEIN$.	1
438	@PROTEIN$ inhibits toll-like receptor 3-induced @COMPOUND$ production in Schwann cells and subsequent sensory neuronal cell death in vitro.	1
439	@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1
440	Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0
441	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
442	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
443	Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1
444	The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1
445	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
446	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
447	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
448	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
449	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
450	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
451	@COMPOUND$ (H2S) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
452	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
453	@COMPOUND$ (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
454	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
455	Pretransplant conditioning consisted of @COMPOUND$, l-@PROTEIN$ and TBI (2 Gy).	0
456	In conclusion, @COMPOUND$-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of TAD and 0.8 mL of 44 w/w % @PROTEIN$ solution.	0
457	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of @COMPOUND$ (PCL): (1) degradation rate (catalysed by @PROTEIN$), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	1
458	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0
459	Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
460	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
461	@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0
462	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
463	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
464	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
465	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
466	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
467	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
468	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
469	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
470	These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1
471	These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1
472	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
473	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
474	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-@PROTEIN$ and Src signaling pathways.	1
475	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and @PROTEIN$ signaling pathways.	1
476	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the @PROTEIN$-Stat3 and Src signaling pathways.	1
477	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
478	Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify @PROTEIN$ as a receptor of @COMPOUND$ epitope.	1
479	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the @COMPOUND$ consumed in the @PROTEIN$ reaction.	1
480	Obesity increases @PROTEIN$ resistance and @COMPOUND$ intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	0
481	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
482	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
483	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
484	To investigate the metabolism of @COMPOUND$ through the @PROTEIN$ (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	1
485	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, tumor necrosis factor-alpha (@PROTEIN$), and @COMPOUND$ (NO).	0
486	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, @PROTEIN$-alpha (TNF-alpha), and @COMPOUND$ (NO).	0
487	Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and @PROTEIN$ were higher in @COMPOUND$-treated animals at this time-point.	1
488	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
489	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
490	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
491	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
492	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
493	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
494	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
495	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
496	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
497	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
498	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with @PROTEIN$ (TGase) production and cell sporulation were investigated.	1
499	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with transglutaminase (@PROTEIN$) production and cell sporulation were investigated.	1
500	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive cortisone to active @COMPOUND$.	1
501	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive @COMPOUND$ to active cortisol.	1
502	Cytochrome P450 (CYP) 1A1 and @PROTEIN$ are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
503	Cytochrome P450 (@PROTEIN$) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
504	@PROTEIN$ (CYP) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
505	@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the @PROTEIN$ and CYP1B1 genes.	0
506	@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and @PROTEIN$ genes.	0
507	@COMPOUND$ treatment leads to recruitment of the @PROTEIN$ to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes.	1
508	These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of @PROTEIN$ than that of CYP1A1 and may be related to the more modest inducibility of the former.	1
509	These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of CYP1B1 than that of @PROTEIN$ and may be related to the more modest inducibility of the former.	1
510	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human CYP1A1 and @PROTEIN$ genes in their natural chromosomal configurations.	1
511	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human @PROTEIN$ and CYP1B1 genes in their natural chromosomal configurations.	1
512	@COMPOUND$ upregulates @PROTEIN$ activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.	1
513	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
514	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
515	Purification, characterization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds.	1
516	Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds (CRLII).	1
517	By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0
518	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0
519	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
520	@PROTEIN$- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by @COMPOUND$.	1
521	The culture medium was analyzed for pH value, concentration of free calcium and @COMPOUND$ and @PROTEIN$.	0
522	SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0
523	@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1
524	SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0
525	Reduced responses of alpha-MSH or @PROTEIN$-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
526	Reduced responses of alpha-MSH or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type @PROTEIN$ system in nonsurvivors.	0
527	Reduced responses of alpha-MSH or Nac-beta-END IRM to @PROTEIN$ and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
528	Reduced responses of @PROTEIN$ or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
529	The FFA fractions elicited pro-inflammatory responses inducing @PROTEIN$ and intracellular adhesion molecule expression and reactive @COMPOUND$ species (ROS) production in human aortic endothelial cells (HAECs).	0
530	This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
531	This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
532	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
533	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
534	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
535	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
536	This study was designed to determine the effect of molsidomine (MO), a precursor of @COMPOUND$ (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
